Related by context. All words. (Click for frequent words.) 65 MLL2 65 KRAS oncogene 65 C#Y 64 KIF6 gene 64 F#del mutation 64 CCR5 delta# 64 autosomal recessive disease 63 hypereosinophilic syndrome 63 BRAF V#E 63 cause cardiac channelopathies 63 apolipoprotein E4 63 CDKN2A 63 III EGFRvIII 63 progranulin gene 63 MYH9 gene 62 PDGFRA 62 germline mutations 62 K ras mutations 62 CDH1 62 von Hippel Lindau 62 non mutated KRAS 62 BRCA1 BRCA2 62 HIV coinfected 62 Atypical Hemolytic Uremic Syndrome 61 LRAT 61 TCF#L# gene 61 hypermethylated 61 mutated K ras 61 GRNOPC1 contains 61 K#N 61 M#V 61 Multidrug resistant 61 Janus kinase 61 pulmonary Pseudomonas aeruginosa 61 BMPR2 61 chronic eosinophilic leukemia 60 Leukemias 60 mycobacterium tuberculosis 60 Lymphocytic 60 clade B 60 del 5q MDS 60 Systemic lupus erythematosus SLE 60 cholesteryl ester transfer 60 TTR gene 60 MELAS 60 Epstein Barr virus EBV 60 Vidaza ® 60 UGT#A# * 60 dopamine D4 receptor 60 ABCB1 60 Chronic lymphocytic leukemia 60 antisense therapies 60 GPC5 60 CYP#C# * 60 NS5b 60 TRAF1 C5 60 Epstein Barr Virus EBV 60 autosomal recessive 60 essential thrombocythemia ET 59 BRIP1 59 CFTR cystic fibrosis transmembrane 59 homozygous FH 59 missense mutations 59 sickle cell cystic fibrosis 59 IL#R 59 HLA DQ2 59 nephronophthisis 59 apolipoprotein E gene 59 discontinued Viread 59 HBeAg negative 59 Gleevec resistant 59 BARD1 59 VKORC1 59 Tay Sachs thalassemia 59 LRP5 59 Nonalcoholic fatty liver 59 SHANK3 59 HLA DR4 immune 59 BRAC2 59 hemagglutinin H 59 myelodysplastic myeloproliferative diseases 59 CYT# potent vascular disrupting 59 breast cancer genes BRCA1 59 Philadelphia Chromosome Positive 59 Acute myeloid leukemia 59 cytopathic 59 CYP#A# CYP#D# 59 castrate resistant 59 causative mutations 59 Chlamydia trachomatis 59 chronic granulomatous disease 59 JAK2 enzyme 58 refractory chronic lymphocytic 58 UGT#B# 58 syngeneic 58 glutamic acid decarboxylase 58 GNAQ 58 acid phosphatase PAP 58 Polymorphisms 58 monogenic 58 Highly pathogenic 58 MLH1 58 MTHFR 58 constitutively activated 58 MAGE A3 protein 58 T#I [002] 58 FLT3 58 nilotinib Tasigna ® 58 non nucleoside inhibitor 58 Ribavirin causes 58 variant allele 58 severe congenital neutropenia 58 kidney urologic 58 autosomal recessive disorder 58 Azacitidine 58 oropharyngeal candidiasis OPC 58 Cryptococcus neoformans 58 LHRH receptor positive 58 Severe Sepsis 58 metastatic neuroendocrine tumors 58 APOA5 58 Heterozygous 58 NOTCH1 58 relapsed MM 58 dasatinib Sprycel 58 H. influenzae 58 NRTI resistance 58 Hepsera adefovir dipivoxil 58 promoter methylation 58 human leukocyte antigen HLA 58 Cathepsin B 58 resistant hormone refractory 58 LPA gene 58 BRCA2 carriers 58 regulator CFTR gene 58 SOD2 gene 58 Bordetella pertussis 58 human metapneumovirus 58 Familial Adenomatous Polyposis FAP 58 SLITRK1 58 PTPN# 58 ENPP1 58 NPM1 gene 58 receptor tyrosine kinase inhibitor 58 Trichomonas vaginalis 58 HLA DR2 58 symptomless carriers 58 novel VDA molecule 58 neuroblastoma tumors 58 TGFBR1 * 6A 58 Myelodysplastic syndromes 58 Ph + acute lymphoblastic 58 variant rs# 58 AML MDS 58 pathophysiological effects 58 Non Alcoholic Steatohepatitis 58 germline mutation 58 Li Fraumeni syndrome 58 FLT3 mutations 58 Thorough cooking kills 57 bacterium Mycobacterium tuberculosis 57 catechol O methyltransferase COMT 57 HLA DRB1 * 57 R#W [002] 57 advanced metastatic renal 57 NPC1 57 HBV genotype 57 brivanib 57 Neisseria 57 cisplatin resistant 57 e antigen HBeAg 57 GBMs 57 orally administered inhibitor 57 MAGE A3 ASCI 57 tumors GIST 57 refractory anemia RA 57 MSH2 57 GSTP1 57 alpha folate receptor 57 dyskeratosis congenita 57 JAK2 gene 57 Protein Kinase C 57 familial pancreatic cancer 57 dasatinib Sprycel ® 57 Moraxella catarrhalis 57 NNRTI resistance 57 KRAS mutations 57 LymphoStat B belimumab 57 Omacetaxine 57 methylenetetrahydrofolate reductase 57 VIPR2 57 APOL1 57 HLA B# 57 DNA methyltransferase inhibitors 57 Salmonella Shigella 57 anti PlGF 57 COPEGUS R 57 myeloproliferative 57 CC genotype 57 ACC2 57 relapsed ALL 57 inherited mutations 57 Wiskott Aldrich syndrome 57 gastrointestinal stromal tumors GISTs 57 PIK3CA 57 IPAH 57 inverse agonist 57 C1 INH deficiency 57 PLX STROKE targeting 57 pregnancy bacterial vaginosis 57 Aplidin R 57 atypical hemolytic uremic syndrome 57 transthyretin amyloidosis 57 Autoantibodies 57 NASH Huntington 57 pool dies unwept 57 Li Fraumeni 57 ALK gene 57 CETP VV 57 TP# mutations 57 familial ALS 57 recurrent glioblastoma multiforme 57 IDH1 gene 57 R5 tropic 57 C. trachomatis 57 Homozygous 56 rs# [004] 56 TCF#L# 56 ADPKD 56 systemic juvenile idiopathic 56 IDH1 mutation 56 cell acute lymphoblastic 56 vWD 56 Naive Patients 56 cyclin dependent kinase inhibitor 56 Yamanaka recipe 56 Tyrosine Kinase Inhibitor 56 maternally inherited 56 Subtype 56 K#R [002] 56 antiretroviral naïve 56 Arranon 56 glutamic acid decarboxylase GAD 56 BRAF gene mutations 56 DICER1 gene 56 Chlamydia pneumoniae 56 Hepatitis B HBV 56 unmutated 56 Leydig cells 56 cisplatin gemcitabine 56 deCODE AF TM 56 GSTT1 56 CYP#C# [002] 56 A. fumigatus 56 EGFR mutation positive 56 SCN5A 56 complement inhibitor eculizumab 56 transthyretin TTR 56 RhuDex ™ 56 DQB1 * 56 Kinase Inhibitor 56 cutaneous T 56 Herpes simplex virus 56 leukemia AML 56 TRAIL induced apoptosis 56 herpesviruses 56 P. ovale 56 hepatoma 56 CFTR corrector 56 Sudhir Agrawal D.Phil 56 Pharmacokinetics PK 56 M. leprae 56 metastatic colorectal 56 genus Plasmodium 56 TMEM#B 56 subtyped 56 narcolepsy cataplexy 56 circulating endothelial cells 56 papillary renal cell carcinoma 56 Karayiorgou 56 Simian Immunodeficiency Virus 56 P. aeruginosa infection 56 breast carcinomas 56 c KIT 56 paternally inherited 56 P. reichenowi 56 nucleoside analog 56 KCNQ1 56 selectively inhibited 56 nonmetastatic 56 Temsirolimus 56 potent inducer 56 novel tubulin binding 56 SOD1 gene 56 metastatic malignant 56 Mg Uk 56 p# deficient 56 Multiple Myeloma MM 56 Epidermal Growth Factor Receptor 56 Enterobacter 56 TACI mutations 56 VHL gene 56 Heterozygous Familial Hypercholesterolemia 56 ovarian endometrial 56 hMPV 56 muscular dystrophy cystic fibrosis 56 ABCB1 gene 56 alvespimycin 56 progressive neurodegenerative disorder 56 squamous cell lung cancer 56 Bronchiectasis 56 IL#B 56 myasthenia gravis MG 56 non CF bronchiectasis 56 relapsed refractory AML 56 microcephalin 56 MYBPC3 56 Squamous 56 Soft Tissue Sarcoma 56 CHD7 56 SCN1A 56 leukemia lymphomas 56 CYP#A# gene 56 TO AVOID PREGNANCY WHILE 56 bladder ovarian 56 amebiasis 56 relapsing remitting MS RRMS 56 Trypanosoma brucei 56 acadesine 56 infects pigs 56 conductance regulator 56 haematopoietic 56 Pneumococcal pneumonia 55 SNP rs# [001] 55 PNP inhibitor 55 Waldenstrom macroglobulinemia 55 HFE gene 55 TTR amyloidosis 55 BRAF V#E mutation 55 myeloproliferative neoplasms 55 chronic myeloid 55 LRRK2 gene 55 FUSILEV enhances 55 G#S [002] 55 Genotypes 55 CYP#C# gene 55 humanized interleukin 6 55 lung cancer NSCLC 55 Wwox 55 K ras gene 55 ApoE4 gene 55 C#T [001] 55 avian H#N# 55 ABSSSI 55 gefitinib Iressa 55 5 HT2A serotonin 55 oral ghrelin agonist 55 Enzastaurin 55 NOMID 55 irreversible inhibitor 55 infliximab monotherapy 55 calcium calmodulin dependent 55 Pseudomonas lung 55 XYOTAX TM 55 NF1 gene 55 Poliovirus 55 APOE4 55 Letairis ambrisentan 55 p# biomarker 55 fluconazole resistant 55 abacavir Ziagen 55 cytolytic 55 vesicular stomatitis virus 55 virus HBV 55 asymptomatic carriers 55 abnormal methylation 55 Cytotoxic T 55 SSc 55 enteroviral 55 Sapacitabine 55 somatostatin 55 USA# strain 55 IMiDs ® 55 cagA 55 activating mutations 55 Escherichia coli Klebsiella pneumoniae 55 pancreatic endocrine 55 Streptococcus agalactiae 55 MGUS 55 simplex virus 55 INF2 55 mda 7 55 Kit CD# positive 55 P aeruginosa 55 heterozygous 55 allelic variants 55 hereditary predisposition 55 ZNF# 55 CCR5 receptor antagonist 55 pyogenes 55 SHANK3 gene 55 immunodeficiencies 55 HER2 overexpression 55 Taenia 55 proteasome inhibitor 55 genotype 1a 55 oligodendrogliomas 55 LMNA 55 Congenital Emphysema 55 paramyxoviruses 55 cynomolgus macaques 55 PEGylated Fab fragment 55 Haptoglobin 55 smoldering myeloma 55 reversible inhibitors 55 5 HT4 55 HLA DR4 55 Entamoeba histolytica 55 Mycobacterium tuberculosis MTB 55 lung ovary 55 ThermoDox ® clinical 55 acute myelogenous leukemia AML 55 leukemia CLL 55 Monoamine oxidase 55 #S ribosomal RNA 55 B Raf 55 IDH2 55 mitotic catastrophe 55 Trichophyton rubrum 55 candidemia 55 eIF 4E 55 RAV# 55 S. pyogenes 55 includes S. anginosus 55 FGFR2 55 CCL#L# 55 hepatitis C HCV 55 PCSK9 gene 55 missense mutation 55 vancomycin resistant 55 paclitaxel cisplatin 55 Human papilloma virus 55 resistant isolates 55 Vidaza R 55 Single Nucleotide Polymorphisms SNPs 55 hematological malignancy 55 Relapsing remitting MS 55 murine leukemia virus 55 EGFR gene 55 NPM1 mutations 55 MC1R gene 55 Alfacell proprietary ribonuclease 55 HMGCR 55 genes predisposing 55 IAP inhibitor 55 herpes zoster shingles 55 Antibiotic resistant 55 binds selectively 55 susceptibility alleles 55 TEL AML1 55 PROSTVAC VF 55 hemagglutinin molecule 55 acute myeloid 55 urate oxidase 55 Monoclonal antibody 55 TMPRSS2 ERG fusion 54 GCase 54 Systemic Sclerosis 54 HER1 54 cyclophosphamide methotrexate 54 HPV subtypes 54 mutated p# 54 ASCUS 54 CYP#D# gene 54 reduce serum phosphate 54 gene MECP2 54 Chronic Myelogenous Leukemia 54 anaplastic lymphoma kinase ALK 54 COL#A# 54 number NCT# ClinicalTrials.gov 54 poor metabolizers 54 Upregulation 54 mildly symptomatic 54 #q# deletion 54 HLA DRB1 54 homozygotes 54 chromosome #p# [002] 54 CDK4 54 Mycoplasma pneumoniae 54 NKX#.# 54 telomerase reverse transcriptase 54 myocardial infarction ventricular fibrillation 54 bevacizumab Avastin R 54 xeroderma pigmentosum 54 preferentially bind 54 GPNMB 54 S. intermedius 54 DEB# 54 Cloretazine 54 null responder 54 mTOR mammalian target 54 virus XMRV 54 Ets2 54 CALHM1 54 receptor blocker 54 sunitinib Sutent ® 54 Kufs disease 54 unresectable stage 54 HBx 54 Creutzfeld Jakob disease 54 surface proteins hemagglutinin 54 Apolipoprotein E 54 VEGFR2 inhibitor 54 peptidic compound 54 KRAS mutant 54 L. pneumophila 54 alpha2 54 IMiDs ® compound 54 chimeric monoclonal antibody 54 cathepsins 54 HuLuc# 54 Plasmodium vivax 54 proband 54 oncogenic mutations 54 vivax 54 Neuroendocrine tumors 54 succinate dehydrogenase 54 MC4R gene 54 aMCI precursor 54 sporadic Creutzfeldt Jakob 54 BRAF gene 54 Sprycel dasatinib 54 diffuse gastric 54 Triapine 54 TP# gene 54 HIV HCV coinfected 54 peptide receptor 54 1 diabetes T1D 54 STK# gene 54 nonalcoholic steatohepatitis NASH 54 T. vaginalis 54 reverse transcriptase inhibitors 54 metaplasia 54 CFTR gene 54 Fragile X gene 54 HIV uninfected 54 Myelodysplastic Syndrome MDS 54 NMDA N 54 protozoan parasite 54 naïve HCV 54 intraepithelial neoplasia 54 malignant ovarian 54 susceptibility loci 54 refractory NSCLC 54 J. Clin 54 beta 1a 54 BARACLUDE ® 54 Corynebacterium 54 fatal myelination disorder 54 parainfluenza viruses 54 Oral Fingolimod 54 bacterium Neisseria meningitidis 54 Alemtuzumab 54 APOE e4 54 aplastic anemia AA 54 advanced hepatocellular carcinoma 54 flavivirus 54 virus subtype 54 demonstrated antitumor activity 54 E#F# 54 Streptococcus pyogenes 54 heterozygotes 54 untreated metastatic pancreatic 54 relapsed leukemia 54 IgA deficiency 54 superantigens 54 Tofacitinib 54 #q#.# [001] 54 metastatic gastric 54 interferon lambda 54 apolipoprotein E 54 toenail onychomycosis 54 mCRPC 54 Aortic stenosis 54 medulloblastoma tumors 54 LHON 54 V#F mutation 54 Creutzfeldt Jacob 54 hormone receptor negative 54 dengue serotype 54 Chronic Lymphocytic Leukemia CLL 54 pancreatic prostate 54 constitutively expressed 54 Hodgkin lymphoma HL 54 HCV polymerase 54 #p#.# [002] 54 vinca alkaloids 54 unresectable recurrent 54 familial aggregation 54 Nosema apis 54 nonsense mutations 54 bexarotene 54 Glioblastoma multiforme GBM 54 M. pneumoniae 54 CD#c 54 gene locus 54 susceptibility gene 54 autosomal dominant disorder 54 chemoresistant 54 Chronic lymphocytic leukemia CLL 54 advanced pancreatic neuroendocrine 54 RhuDex R 54 cortisol synthesis 54 5 FU leucovorin 54 ORMDL3 54 ceftazidime 54 Cutaneous T 54 HepG2 cells 54 chromosome #q# [002] 54 methicillin susceptible Staphylococcus aureus 54 refractory acute myeloid 54 Uterine cancer 54 homozygous familial hypercholesterolemia 54 PEGylated anti 54 AEG# 54 minimally symptomatic metastatic castrate 54 thalidomide Thalomid 54 EGFR mutant 54 GG genotype 53 causes Chagas disease 53 investigational oral inhibitor 53 MDRSP 53 E. coli STEC 53 antiretroviral naive 53 pentamidine 53 recurrent acute pancreatitis 53 tumor specific antigen 53 hypersensitivity reactions eg anaphylaxis 53 #p#.# [001] 53 potent antiproliferative 53 Hurthle cell 53 HCV replicon 53 monocytic 53 JAK2 mutation 53 biologic DMARD 53 Hp2 2 53 Macrophage 53 TOP2A 53 null responder HCV 53 subtype H#N# 53 #q# [001] 53 squamous histology 53 nonhematologic adverse reactions 53 anaplastic lymphoma kinase 53 adrenoceptor 53 coagulase negative staphylococci 53 androgen receptor gene 53 Gorlin syndrome 53 KCNH2 53 Hsp# Inhibitor 53 NPHP 53 Lung transplantation 53 colorectal carcinoma 53 EGFR mutations 53 ALI ARDS 53 Enterobacter cloacae 53 recurrent NSCLC 53 decompensated liver disease 53 Thiarabine 53 AVAPRO 53 stage IIIb IV 53 HCV SPRINT 53 HNPCC 53 PRNP 53 PDGFR 53 SLC#A# [001] 53 Ehrlichia 53 coinfected 53 chromosome #q# [001] 53 nucleotide analogue 53 Chronic pancreatitis 53 upregulates 53 Polymorphism 53 Chronic myeloid leukemia 53 Polymerase Inhibitor 53 XMRV infection 53 replicon 53 Fibroblast 53 erlotinib Tarceva ® 53 tramiprosate Alzhemed TM 53 subependymal giant cell 53 HLA loci 53 Trypanosoma cruzi 53 oseltamivir resistant influenza 53 ALN TTR 53 unmethylated 53 receptor inhibitor 53 antiangiogenic agent 53 HLA A2 53 autoantibody positive 53 uncomplicated influenza 53 transgenic rats 53 selective kinase inhibitor 53 Inactivation 53 MTHFR gene 53 PD LID 53 HER2 positive cancers 53 Varicella zoster virus 53 CD3 + 53 Staphylococcus epidermidis 53 Clade B 53 small lymphocytic lymphoma 53 JAK mutations 53 apoE4 53 alpha1 antitrypsin deficiency 53 idiopathic PAH 53 clade C 53 Human papillomavirus HPV 53 intestinal metaplasia 53 Anaplasma 53 Acute lymphoblastic leukemia 53 coxsackie 53 MDR1 53 glycopeptide 53 Aurora Kinase 53 vinca alkaloid 53 SGPT 53 apolipoprotein E APOE 53 DRD2 53 monocytes macrophages 53 normal karyotype 53 myelofibrosis polycythemia vera 53 D aspartate NMDA receptor 53 mutated KRAS gene 53 elevated triglyceride levels 53 mitogen activated protein kinases 53 PB2 gene 53 aggressive systemic mastocytosis 53 asymptomatic metastatic 53 gene rearrangements 53 HCV infected 53 Mg Usa 53 Papillary 53 gene polymorphism 53 Autoimmune hepatitis 53 MECP2 gene 53 RTP #i 53 Annamycin 53 immuno compromised individuals 53 pancreatic neuroendocrine tumors 53 mutated BRAF gene 53 HIV reverse transcriptase 53 Vesivirus 53 chemokine receptor 53 HMPV 53 CHEK2 53 endogenous retrovirus 53 Germline 53 chromosome #p# [001] 53 simian foamy virus 53 NFkB 53 ε4 53 #p# [003] 53 immunocompetent adults 53 Tesmilifene 53 familial hypercholesterolemia 53 ccRCC 53 Novel Oral 53 HER2 neu 53 Prolongs Survival 53 potently inhibits 53 KRAS gene 53 chronic HBV infection 53 ErbB1 53 aneuploid 53 pulmonary P. aeruginosa 53 mGluR5 antagonist 53 Sipuleucel T 53 CALGB 53 Factor Receptor 53 ERBB2 53 cytomegalovirus CMV 53 lacunar 53 Salmonella typhi 53 serine threonine kinase 53 HQK 53 agonistic human 53 Tarceva TM 53 pneumococci 53 staphylococci 53 surgically resected 53 primary humoral immunodeficiency 53 PALB2 53 Aviptadil 53 B. cereus 53 CTAP# Capsules 53 Phase #b/#a clinical 53 Acute Myeloid Leukaemia AML 53 decarboxylase 53 IMiDs R 53 precursor acute lymphoblastic 53 androgen receptor AR 53 seronegative 53 hormone refractory metastatic prostate 53 ApoE4 53 enterococcal 53 potently inhibited 53 Angiotensin converting enzyme 53 Interferon gamma 53 H#N# monovalent vaccine 53 metastatic bladder 53 Plasmodium ovale 53 recurrent metastatic 52 vinorelbine tartrate 52 CPVT 52 polycythemia vera PV 52 chronic idiopathic thrombocytopenic purpura 52 pediatric acute lymphoblastic 52 5 HTTLPR 52 dacarbazine DTIC 52 beta carotene supplementation 52 CCR5 mAb 52 DRD2 gene 52 virulence genes 52 hepatic lipase 52 S. enterica 52 chronically immunosuppressed solid 52 Moraxella bovis 52 falciparum 52 Cytomegalovirus CMV 52 heavily pretreated 52 M. genitalium 52 TRIM5a 52 Evoltra ® 52 relapsed acute myelogenous 52 molecule epidermal 52 lung adenocarcinomas 52 CD# + [001] 52 JAK2 inhibitor 52 methyl D aspartate 52 EGFR mutation 52 sexually transmitted HPV 52 radiation chemoradiation 52 APOE genotype 52 splice variants 52 SNPs pronounced snips 52 Candida species 52 basal cell carcinoma BCC 52 Oncogenic 52 microdeletions 52 ApoE4 allele 52 Hutchinson Gilford progeria 52 CREBBP 52 FLT3 ITD 52 INSPIRE Trial Phase III 52 metastatic hormone refractory 52 parkin gene 52 IKZF1 52 SMN1 52 cell lymphoma CTCL 52 apoptosis proteins 52 S. maltophilia 52 copper zinc superoxide 52 lymphocytic choriomeningitis virus LCMV 52 filoviruses 52 tarenflurbil 52 autosomal recessive genetic 52 CCR5 tropic HIV 52 AIR CF1 52 KIAA# 52 neurological manifestations 52 stage IIIB 52 sporadic ALS 52 Myotonic dystrophy 52 WDR# 52 activating mutation 52 dirucotide MBP# 52 variola 52 Phase #/#a trial 52 DU# [002] 52 mRNA transcripts 52 SGS# 52 thrombocytopenic 52 de novo coronary artery 52 Winnipeg MB R2X 52 leiomyomas 52 L#R 52 androgen receptor antagonist 52 Estrogen Receptor 52 irinotecan doxorubicin oxaliplatin paclitaxel 52 ATG#L# 52 xenotropic murine leukemia 52 rs# [003] 52 cell adhesion molecule 52 downstream effectors 52 D#N 52 Kinase Inhibitors 52 huntingtin gene 52 isoenzyme 52 HuMax 52 catechol O methyltransferase 52 transiently transfected 52 CYP #D# 52 Survivin 52 H5 viruses 52 efficacy evaluable 52 visit www.cff.org 52 M2 subunit 52 HER2 HER2 52 dose intramuscular 52 Chronic myeloid leukemia CML 52 Bezielle 52 Brugada syndrome 52 tuberculin skin testing 52 interferon beta 1a infertility 52 SPINK1 52 paraganglioma 52 KRAS wild 52 heterozygote 52 latently infected 52 TACI 52 radezolid 52 lymphoid malignancies 52 alpha1 antitrypsin AAT deficiency 52 virus HCV infection 52 Aromatase 52 neutralizing antibody responses 52 #p# [001] 52 mRCC 52 Previously Untreated 52 Pulmonary arterial hypertension 52 prion gene 52 pDC 52 NS#/#A protease 52 Intravenous immunoglobulin 52 Xanafide 52 reversible inhibitor 52 lymphoproliferative disorders 52 treatment naïve genotype 52 adhesion molecule EpCAM expressing 52 DRB1 * 52 Clusterin 52 factor HGF 52 ADP receptor antagonist 52 Malignant Melanoma 52 MEF2A 52 selective agonists 52 T#I mutant 52 orthologs 52 GBA mutations 52 hypercholesterolemia liver 52 cytogenetic abnormalities 52 nonsmall cell lung cancer 52 vesicular monoamine transporter 52 cholangiocarcinoma 52 Insegia 52 microsatellite instability 52 V#E 52 PNET 52 adamantanes 52 Twinrix 52 clonally 52 YONDELIS 52 hepatitis C genotype 52 Lafora disease 52 Velcade bortezomib 52 chronic HBV 52 de novo mutations 52 haematopoietic stem cell 52 arthritis PsA 52 progesterone receptor negative 52 Borrelia burgdorferi 52 transmembrane receptor 52 ovarian breast 52 Enterococcus faecalis 52 Bruton tyrosine kinase 52 Alleles 52 NPC 1C 52 CYP#A# [002] 52 CanAg 52 FMR1 52 #q# [002] 52 mGluR 52 thymidine kinase 52 PAOD 52 chromosome #p#.# 52 myeloid 52 multi kinase inhibitor 52 functional polymorphism 52 COPEGUS therapy 52 NR#A# gene 52 prostanoid 52 FUS TLS 52 genotypic resistance 52 missense 52 WAGR syndrome 52 juvenile idiopathic arthritis JIA 52 HCV genotypes 52 NSCLC tumors